Core Insights - Beijing Tongrentang has made significant progress in the safety research of traditional Chinese medicine for depression, with results published in key journals [1][2] - The research provides scientific evidence for the clinical safety of medication for postpartum and adolescent depression patients, highlighting the importance of rational drug use [1][2] Group 1: Research Achievements - The studies on the safety of Baijitian oligosaccharide capsules were conducted in collaboration with the National Drug Safety Evaluation and Monitoring Center, focusing on non-clinical safety evaluations for nursing and juvenile animals [2] - The research involved administering doses up to 50 times the maximum daily human dosage, with no abnormal findings in various health indicators of the test animals, confirming the high safety of the capsules [2] Group 2: Product Development and Recognition - Baijitian oligosaccharide capsules, developed jointly with the Academy of Military Medical Sciences, are classified as a new type of traditional Chinese medicine and have received multiple invention patents and the First Prize for Scientific and Technological Progress in Beijing [1] - The product has been included in nine expert consensus and treatment guidelines, establishing it as a core therapeutic drug for mild to moderate depression [1] Group 3: Commitment to Safety and Innovation - The company emphasizes patient needs and adheres to strict standards in product quality, utilizing scientific methods to deepen safety research and ensure medication safety [2] - Beijing Tongrentang's long-standing philosophy of meeting health needs continues to drive innovation in traditional Chinese medicine, contributing to the high-quality development of mental health services in China [2]